Accordingly, it was furthermore reported that TRAF2-deficiency and treatment with TWEAK or IAP antagonists sensitize for tumor cell killing by CD8+ T cell/NK cell-derived TNF (Kearney et al., 2017; Vredevoogd et al., 2019). This evidence concerns the gene TRAF2 and neoplasm.